Cleared Traditional

K842509 - CALCIUM ASSAY KIT

K842509 is the FDA 510(k) clearance for CALCIUM ASSAY KIT by Diagnostic Chemicals, Ltd. (Usa). It is a Class 2 Chemistry device (product code CIC) cleared through the Traditional 510(k) pathway after a 24-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1984
Decision
24d
Days
Class 2
Risk

K842509 is an FDA 510(k) clearance for the CALCIUM ASSAY KIT. Classified as Cresolphthalein Complexone, Calcium (product code CIC), Class II - Special Controls.

Submitted by Diagnostic Chemicals, Ltd. (Usa) (Canada, US). The FDA issued a Cleared decision on July 20, 1984 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1145 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Chemicals, Ltd. (Usa) devices

Submission Details

510(k) Number K842509 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 26, 1984
Decision Date July 20, 1984
Days to Decision 24 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 88d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIC Cresolphthalein Complexone, Calcium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1145
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIC Cresolphthalein Complexone, Calcium

All 67
Devices cleared under the same product code (CIC) and FDA review panel - the closest regulatory comparables to K842509.
CALCIUM
K850281 · Boehringer Mannheim Corp. · Feb 1985
RAICHEM CALCIUM REAGENT
K843353 · Reagents Applications, Inc. · Sep 1984
SYSTEMATE CALCIUM 67214
K843152 · Em Diagnostic Systems, Inc. · Aug 1984
SERUM CALCIUM REAGENT SET
K841051 · Medical Specialties, Inc. · May 1984
FLOW-PAC CALCIUM REAGENT SET
K834336 · American Research Products Co. · Feb 1984
CALCIUM DYE REAGENT-CS-718-A/BUFFER
K833035 · Fisher Scientific Co., LLC · Nov 1983